This Is MS Multiple Sclerosis Knowledge & Support Community

The flawed point is that the study population has significantly decreased. So it seems obvious to me that only the people that did very well on Copaxone, (or what seems more likely to me) people who have a naturally benign course stayed in the trial, while people with less benefit dropped out of th...

I started with every day copax for 3 years then went to every other day for the next 4 1/2. At that point my annual mri showed a crop of new lesions. (this was also during a very stressful period when it looked like my wife had ovarian cancer) Back on every day for the last 6 months and just complet...

Copaxone is not a perfect match for everybody that's for sure. I've been on it now for over 6 years. 3 years of everyday shots, 3+ years of every other day shots. So far so good. My yearly MRI's have been stable, I've gone from almost being unable to leave the house for a couple years to back workin...

What????? Is this the same Harry who is always ready to put down Copaxone on this very web site?

So he stirs debate, so what. It's a good thing to hear both sides of such a serious issue.

I vote to keep him on the island.

Try this link, http://press.psprings.co.uk/bmj/february/ac416.pdf

Interesting stuff.

There's another possible reason people dropped out of the Copaxone trial, maybe they were doing too well on the drug. After injecting for years and having little or no noticeable progression a person may just feel that they don't need the drug, that their ms is a more benign form and they don't need...

The advertising push has begun. I received an invitation yesterday from Biogen to a seminar on the benefits of a once a month infusion over regular injection therapy's.

Harry, this is old news. Not much has been shown to help PP to date. The PROMiSe trial: baseline data review and progress report. Wolinsky JS; PROMiSe Trial Study Group. University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA. jswolinsky@aol.com The PROMiSe t...

Great news, thanks

Biogen took 11 days to act on MS drug warning By Richard Irving SENIOR executives at Biogen Idec are to face fresh questions over share dealings and bonus awards after a senior doctor working on a crucial trial of Tysabri warned the drug developer that a patient had suffered adverse side-effects as ...

Harry,The second patient did die or so I read this morning. As far as the death rate from PML, there was an article in the Boston Globe yesterday where they talked with the top PML expert in the country. He said they've got the death rate down to about 50%.

Peter

Dawn, I know of one person who claims to have had his immune system wiped out who posts over at braintalk, I must have missed the other one that Phirex is talking about. I followed the story of the one I know of during the time he was getting infected. He had a very strange habit of injecting copaxo...

No, none is required but I still go have bloodwork done once a year to make sure my liver is still functioning ok.

I thought this was kind of interesting, from the NYT today: But Lawrence Steinman, a professor of neurology and head of immunology at Stanford, said the F.D.A. should not have approved the drug on the basis of only one year's data. He said the risk of serious infections like P.M.L. was "unfortu...

The WSJ and Bloomberg news have been trolling msworld and probably other sites for on the record reaction from real mser's.